Skip to Content
Merck
  • Directed differentiation of human pluripotent stem cells into epidermal keratinocyte-like cells.

Directed differentiation of human pluripotent stem cells into epidermal keratinocyte-like cells.

STAR protocols (2022-08-23)
Gowher Ali, Essam M Abdelalim
ABSTRACT

The human pluripotent stem cell (hPSC) differentiation has allowed for the generation of in vitro models to study human diseases in a dish. This protocol describes the generation of keratinocyte-like cells from hPSCs in chemically defined media. Treating hPSCs with retinoic acid and BMP4 induced the generation of keratinocyte progenitors, which further differentiated into mature keratinocytes in the presence of calcium. The keratinocytes generated with this protocol could be used to study keratinocyte biology, drug screening, and skin-related diseases. For complete details on the use and execution of this protocol, please refer to Ali et al. (2020).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Bovine Serum Albumin, heat shock fraction, protease free, fatty acid free, essentially globulin free, pH 7, ≥98%
Sigma-Aldrich
Anti-Cytokeratin 19 Antibody, clone BA 17, clone BA 17, Chemicon®, from mouse